Abstract The current work examined the therapeutic potential of 6-aminoflavone (6AF) against mouse model-based oxidative stress-driven synaptic and memory impairment caused by lipopolysaccharides (LPSs). In the brains of the experimental… Click to show full abstract
Abstract The current work examined the therapeutic potential of 6-aminoflavone (6AF) against mouse model-based oxidative stress-driven synaptic and memory impairment caused by lipopolysaccharides (LPSs). In the brains of the experimental mice, LPS administration for 3 weeks significantly increased oxidative stress by inhibiting antioxidant enzymes, including superoxide dismutase, peroxidase, catalase, glutathione, and upregulating lipid peroxidase. Male albino mice were arbitrarily divided into four groups including (1) Control, (2) LPS treated (250 µg/kg, for 3 weeks), (3) LPS plus 6AF treated (30 mg/kg for 2 weeks), and (4) 6AF treated (30 mg/kg for 2 weeks). Different antioxidant enzyme assays, behavior tasks, and the western blotting technique were used to test the therapeutic potentials of this 6AF. Remarkably, the dosage of 6AF significantly reversed the activities of antioxidant enzymes and reduced neuroinflammation in adult albino mice. Additionally, 6HF also improved the synapse (both pre- and post-proteins) and restored the impaired memory against LPS. In short, these findings propose that 6AF is a natural, non-toxic, and potent therapeutic agent to treat neurodegenerative diseases.
               
Click one of the above tabs to view related content.